The DOI matches its Crossref record; 314 of the 314 references it cites were found in a registry or an index.
The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
Open accessAbstract
Hypoxia is an integral component of the tumor microenvironment. Either as chronic or cycling hypoxia, it exerts a similar effect on cancer processes by activating hypoxia-inducible factor-1 (HIF-1) and nuclear factor (NF-κB), with cycling hypoxia showing a stronger proinflammatory influence. One of the systems affected by hypoxia is the CXC chemokine system. This paper reviews all available information on hypoxia-induced changes in the expression of all CXC chemokines (CXCL1, CXCL2, CXCL3, CXCL4, CXCL5, CXCL6, CXCL7, CXCL8 (IL-8), CXCL9, CXCL10, CXCL11, CXCL12 (SDF-1), CXCL13, CXCL14, CXCL15, CXCL16, CXCL17) as well as CXC chemokine receptors—CXCR1, CXCR2, CXCR3, CXCR4, CXCR5, CXCR6, CXCR7 and CXCR8. First, we present basic information on the effect of these chemoattractant cytokines on cancer processes. We then discuss the effect of hypoxia-induced changes on CXC chemokine expression on the angiogenesis, lymphangiogenesis and recruitment of various cells to the tumor niche, including myeloid-derived suppressor cells (MDSCs), tumor-associated macrophages (TAMs), tumor-associated neutrophils (TANs), regulatory T cells (Tregs) and tumor-infiltrating lymphocytes (TILs). Finally, the review summarizes data on the use of drugs targeting the CXC chemokine system in cancer therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Roth, G. A., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32203-7 · Cited by 8,600
Involvement of chemokine receptors in breast cancer metastasis
Müller, A., Homey, B., Soto, H., Ge, N., Catron, D., Buchanan, M. E., McClanahan, T., Murphy, E., Yuan, W., Wagner, S. N., et al. (2001) · Nature · doi:10.1038/35065016 · Cited by 5,340
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,859
Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1
Ceradini, D. J., Kulkarni, A. R., Callaghan, M. J., Tepper, O. M., Bastidas, N., Kleinman, M. E., Capla, J. M., Galiano, R. D., Levine, J. P., & Gurtner, G. C. (2004) · Nature Medicine · doi:10.1038/nm1075 · Cited by 2,600 · cited 1×
“This effect is dependent on HIF-1 [212,223,224,227,231] and HIF-2 [158,227].”
BackgroundHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
A comparative encyclopedia of DNA elements in the mouse genome
Yue, F., Cheng, Y., Breschi, A., Vierstra, J., Wu, W., Ryba, T., Sandstrom, R., Ma, Z., Davis, C., Pope, B. D., et al. (2014) · Nature · doi:10.1038/nature13992 · Cited by 1,781 · cited 1×
“CXCL15 is mainly expressed in murine lungs [289], and to a much lesser extent in the murine digestive tract and urogenital organs [80].”
BackgroundHypoxia-Inducible Factor-1 (HIF-1)
Ke, Q., & Costa, M. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.027029 · Cited by 1,646
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch
Lando, D., Peet, D. J., Whelan, D. A., Gorman, J. J., & Whitelaw, M. L. (2002) · Science · doi:10.1126/science.1068592 · Cited by 1,558 · cited 1×
“The regulation of HIF transcriptional activity also involves factor inhibiting HIF (FIH), an enzyme which causes the hydroxylation of asparagine residue [32] and thus disrupts the interaction of HIF-α with the CBP/p300 coactivator [33,34].”
BackgroundA guide to chemokines and their receptors
Hughes, C. E., & Nibbs, R. J. B. (2018) · The FEBS Journal · doi:10.1111/febs.14466 · Cited by 1,412
Role of tumor microenvironment in tumorigenesis
Wang, M., Zhao, J., Zhang, L., Wei, F., Lian, Y., Wu, Y., Gong, Z., Zhang, S., Zhou, J., Cao, K., et al. (2017) · Journal of Cancer · doi:10.7150/jca.17648 · Cited by 1,404
Burns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,263
The Functional Role of the ELR Motif in CXC Chemokine-mediated Angiogenesis
Strieter, R. M., Polverini, P. J., Kunkel, S. L., Arenberg, D. A., Burdick, M. D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.27348 · Cited by 1,222
Masson, N., Willam, C., Maxwell, P. H., Pugh, C. W., & Ratcliffe, P. J. (2001) · The EMBO Journal · doi:10.1093/emboj/20.18.5197 · Cited by 1,014 · cited 1×
“This degradation occurs due to the hydroxylation of HIF-1α and HIF-2α in proline residues by prolyl hydroxylase (PHD), which leads to the ubiquitination by von Hippel-Lindau protein (pVHL) and then to proteolytic degradation of these HIF-α subunits [21].”
BackgroundZhang, C., Samanta, D., Lu, H., Bullen, J. W., Zhang, H., Chen, I., He, X., & Semenza, G. L. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1602883113 · Cited by 971
Regulation of the HIF-1α Level Is Essential for Hematopoietic Stem Cells
Takubo, K., Goda, N., Yamada, W., Iriuchishima, H., Ikeda, E., Kubota, Y., Shima, H., Johnson, R. S., Hirao, A., Suematsu, M., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.06.020 · Cited by 891
Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia
Parmar, K., Mauch, P., Vergilio, J.-A., Sackstein, R., & Down, J. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701152104 · Cited by 867
Regulation of the Chemokine Receptor CXCR4 by Hypoxia
Schioppa, T., Uranchimeg, B., Saccani, A., Biswas, S. K., Doni, A., Rapisarda, A., Bernasconi, S., Saccani, S., Nebuloni, M., Vago, L., et al. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030267 · Cited by 841
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
Hirsilä, M., Koivunen, P., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304982200 · Cited by 794
Cummins, E. P., Berra, E., Comerford, K. M., Ginouves, A., Fitzgerald, K. T., Seeballuck, F., Godson, C., Nielsen, J. E., Moynagh, P., Pouyssegur, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602235103 · Cited by 788
Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1α
Lim, J.-H., Lee, Y.-M., Chun, Y.-S., Chen, J., Kim, J.-E., & Park, J.-W. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.05.023 · Cited by 758 · cited 1×
“One of them is the deacetylation of HIF-1α by sirtuin 1 (SIRT1), which leads to a decrease in HIF-1 transcriptional activity [78].”
BackgroundStructural basis for the recognition of hydroxyproline in HIF-1α by pVHL
Hon, W.-C., Wilson, M. I., Harlos, K., Claridge, T. D. W., Schofield, C. J., Pugh, C. W., Maxwell, P. H., Ratcliffe, P. J., Stuart, D. I., & Jones, E. Y. (2002) · Nature · doi:10.1038/nature00767 · Cited by 751
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
Soeda, A., Park, M., Lee, D., Mintz, A., Androutsellis-Theotokis, A., McKay, R. D., Engh, J., Iwama, T., Kunisada, T., Kassam, A. B., et al. (2009) · Oncogene · doi:10.1038/onc.2009.252 · Cited by 656
Coleman, R. L., Brady, M. F., Herzog, T. J., Sabbatini, P., Armstrong, D. K., Walker, J. L., Kim, B.-G., Fujiwara, K., Tewari, K. S., O'Malley, D. M., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30279-6 · Cited by 609
JunD Reduces Tumor Angiogenesis by Protecting Cells from Oxidative Stress
Gerald, D., Berra, E., Frapart, Y. M., Chan, D. A., Giaccia, A. J., Mansuy, D., Pouysségur, J., Yaniv, M., & Mechta-Grigoriou, F. (2004) · Cell · doi:10.1016/j.cell.2004.08.025 · Cited by 588
Bockorny, B., Semenisty, V., Macarulla, T., Borazanci, E., Wolpin, B. M., Stemmer, S. M., Golan, T., Geva, R., Borad, M. J., Pedersen, K. S., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0880-x · Cited by 557
Salcedo, R., Wasserman, K., Young, H. A., Grimm, M. C., Howard, O. M. Z., Anver, M. R., Kleinman, H. K., Murphy, W. J., & Oppenheim, J. J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65365-5 · Cited by 540
Treins, C., Giorgetti-Peraldi, S., Murdaca, J., Semenza, G. L., & Van Obberghen, E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204152200 · Cited by 539
The use of cobalt chloride as a chemical hypoxia model
Muñoz‐Sánchez, J., & Chánez‐Cárdenas, M. E. (2019) · Journal of Applied Toxicology · doi:10.1002/jat.3749 · Cited by 530
Abnormalities of Basement Membrane on Blood Vessels and Endothelial Sprouts in Tumors
Baluk, P., Morikawa, S., Haskell, A., Mancuso, M., & McDonald, D. M. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63540-7 · Cited by 528 · cited 1×
“Cycling hypoxia has cyclic episodes of oxygen deficiency interspersed with periods of reoxygenation [9]—a result of structural abnormalities in the vascular vessels, particularly the lack of a conventional hierarchy (Figure 1) [10,11].”
BackgroundMu, X., Shi, W., Xu, Y., Xu, C., Zhao, T., Geng, B., Yang, J., Pan, J., Hu, S., Zhang, C., et al. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1444305 · Cited by 509
Hypoxia Induces Vascular Endothelial Growth Factor in Cultured Human Endothelial Cells
Namiki, A., Brogi, E., Kearney, M., Kim, E. A., Wu, T., Couffinhal, T., Varticovski, L., & Isner, J. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.52.31189 · Cited by 492
Heidemann, J., Ogawa, H., Dwinell, M. B., Rafiee, P., Maaser, C., Gockel, H. R., Otterson, M. F., Ota, D. M., Lügering, N., Domschke, W., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208231200 · Cited by 476
Imtiyaz, H. Z., Williams, E. P., Hickey, M. M., Patel, S. A., Durham, A. C., Yuan, L.-J., Hammond, R., Gimotty, P. A., Keith, B., & Simon, M. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39506 · Cited by 461 · cited 3×
“The most important factor increasing the expression of CXCL2 in TAMs is HIF-2 [161].”
BackgroundStructural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1α
Freedman, S. J., Sun, Z.-Y. J., Poy, F., Kung, A. L., Livingston, D. M., Wagner, G., & Eck, M. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082117899 · Cited by 455
Koivunen, P., Hirsilä, M., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312254200 · Cited by 447
Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-κB
Frede, S., Stockmann, C., Freitag, P., & Fandrey, J. (2006) · Biochemical Journal · doi:10.1042/bj20051839 · Cited by 436
BelAiba, R. S., Bonello, S., Zähringer, C., Schmidt, S., Hess, J., Kietzmann, T., & Görlach, A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-04-0391 · Cited by 423
Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis
Jung, Y., Kim, J. K., Shiozawa, Y., Wang, J., Mishra, A., Joseph, J., Berry, J. E., McGee, S., Lee, E., Sun, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms2766 · Cited by 423
Kryczek, I., Lange, A., Mottram, P., Alvarez, X., Cheng, P., Hogan, M., Moons, L., Wei, S., Zou, L., Machelon, V., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.465.65.2 · Cited by 421
Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells
Mizukami, Y., Jo, W.-S., Duerr, E.-M., Gala, M., Li, J., Zhang, X., Zimmer, M. A., Iliopoulos, O., Zukerberg, L. R., Kohgo, Y., et al. (2005) · Nature Medicine · doi:10.1038/nm1294 · Cited by 406
Zagzag, D., Lukyanov, Y., Lan, L., Ali, M. A., Esencay, M., Mendez, O., Yee, H., Voura, E. B., & Newcomb, E. W. (2006) · Laboratory Investigation · doi:10.1038/labinvest.3700482 · Cited by 396
Lactate in the Tumor Microenvironment: An Essential Molecule in Cancer Progression and Treatment
Pérez-Tomás, R., & Pérez-Guillén, I. (2020) · Cancers · doi:10.3390/cancers12113244 · Cited by 385
Romagnani, P., Annunziato, F., Lasagni, L., Lazzeri, E., Beltrame, C., Francalanci, M., Uguccioni, M., Galli, G., Cosmi, L., Maurenzig, L., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci9775 · Cited by 379
The transcriptional factors HIF-1 and HIF-2 and their novel inhibitors in cancer therapy
Albadari, N., Deng, S., & Li, W. (2019) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2019.1613370 · Cited by 351
Chen, J. J. W., Yao, P., Yuan, A., Hong, T.-M., Shun, C., Kuo, M., Lee, Y.-C., & Yang, P. (2003) · PubMed · Cited by 347
Zhang, R., Qi, F., Zhao, F., Li, G., Shao, S., Zhang, X., Yuan, L., & Feng, Y. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1435-2 · Cited by 343
Hypoxic induction of interleukin-8 gene expression in human endothelial cells.
Karakurum, M., Shreeniwas, R., Chen, J., Pinsky, D., Yan, S. D., Anderson, M., Sunouchi, K., Major, J., Hamilton, T., & Kuwabara, K. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117135 · Cited by 340
Marchesi, F., Monti, P., Leone, B. E., Zerbi, A., Vecchi, A., Piemonti, L., Mantovani, A., & Allavena, P. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1343 · Cited by 339
Fang, H.-Y., Hughes, R., Murdoch, C., Coffelt, S. B., Biswas, S. K., Harris, A. L., Johnson, R. S., Imityaz, H. Z., Simon, M. C., Fredlund, E., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195941 · Cited by 319 · cited 5×
“Another important source of CXCL1 and CXCL2 in the hypoxic microenvironment may be TAMs and MDSCs, as chronic hypoxia increases CXCL1 and CXCL2 expression in macrophages [159] and MDSCs [160].”
BackgroundInfluentialYuan, G., Nanduri, J., Khan, S., Semenza, G. L., & Prabhakar, N. R. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21537 · Cited by 310
Azab, A. K., Hu, J., Quang, P., Azab, F., Pitsillides, C., Awwad, R., Thompson, B., Maiso, P., Sun, J. D., Hart, C. P., et al. (2012) · Blood · doi:10.1182/blood-2011-09-380410 · Cited by 301
Hyperbaric oxygen therapy and cancer—a review
Moen, I., & Stuhr, L. E. B. (2012) · Targeted Oncology · doi:10.1007/s11523-012-0233-x · Cited by 298
Taki, M., Abiko, K., Baba, T., Hamanishi, J., Yamaguchi, K., Murakami, R., Yamanoi, K., Horikawa, N., Hosoe, Y., Nakamura, E., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03966-7 · Cited by 296
Shi, Q., Abbruzzese, J. L., Huang, S., Fidler, I. J., Xiong, Q., & Xie, K. (1999) · PubMed · Cited by 293
Increased Prolyl 4-Hydroxylase Domain Proteins Compensate for Decreased Oxygen Levels
Stiehl, D. P., Wirthner, R., Köditz, J., Spielmann, P., Camenisch, G., & Wenger, R. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601719200 · Cited by 289
Stiehl, D. P., Jelkmann, W., Wenger, R. H., & Hellwig-Bürgel, T. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02247-0 · Cited by 285
Hypoxia Up-regulates Prolyl Hydroxylase Activity
D'Angelo, G., Duplan, E., Boyer, N., Vigne, P., & Frelin, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302244200 · Cited by 285
Balsamo, M., Manzini, C., Pietra, G., Raggi, F., Blengio, F., Mingari, M. C., Varesio, L., Moretta, L., Bosco, M. C., & Vitale, M. (2013) · European Journal of Immunology · doi:10.1002/eji.201343448 · Cited by 282
Herrmann, K., Schottelius, M., Lapa, C., Osl, T., Poschenrieder, A., Hänscheid, H., Lückerath, K., Schreder, M., Bluemel, C., Knott, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.167361 · Cited by 276
Ye, L.-Y., Chen, W., Bai, X.-L., Xu, X.-Y., Zhang, Q., Xia, X.-F., Sun, X., Li, G.-G., Hu, Q.-D., Fu, Q.-H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-0977 · Cited by 275
Bilusic, M., Heery, C. R., Collins, J. M., Donahue, R. N., Palena, C., Madan, R. A., Karzai, F., Marté, J. L., Strauss, J., Gatti-Mays, M. E., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0706-x · Cited by 274
Mylonis, I., Chachami, G., Samiotaki, M., Panayotou, G., Paraskeva, E., Kalousi, A., Georgatsou, E., Bonanou, S., & Simos, G. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605058200 · Cited by 266
Zagzag, D., Krishnamachary, B., Yee, H., Okuyama, H., Chiriboga, L., Ali, M. A., Melamed, J., & Semenza, G. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4406 · Cited by 260
Nor, J. E., Christensen, J. B., Liu, J., Peters, M., Mooney, D. J., Strieter, R. M., & Polverini, P. J. (2001) · PubMed · Cited by 257
PHDs overactivation during chronic hypoxia “desensitizes” HIFα and protects cells from necrosis
Ginouvès, A., Ilc, K., Macías, N., Pouysségur, J., & Berra, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705680105 · Cited by 256
Shellenberger, T. D., Wang, M., Gujrati, M., Jayakumar, A., Strieter, R. M., Burdick, M. D., Ioannides, C. G., Efferson, C. L., El-Naggar, A. K., Roberts, D., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2056 · Cited by 250
Winkler, I. G., Barbier, V., Wadley, R., Zannettino, A. C. W., Williams, S., & Lévesque, J.-P. (2010) · Blood · doi:10.1182/blood-2009-07-233437 · Cited by 249
Chao, T., Furth, E. E., & Vonderheide, R. H. (2016) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0188 · Cited by 246
Salcedo, R., Resau, J. H., Halverson, D., Hudson, E. A., Dambach, M., Powell, D., Wasserman, K., & Oppenheim, J. J. (2000) · The FASEB Journal · doi:10.1096/fj.99-0963com · Cited by 245
Desbaillets, I., Diserens, A.-C., Tribolet, N. D., Hamou, M.-F., & Meir, E. G. V. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1201 · Cited by 243
Augsten, M., Hägglöf, C., Olsson, E., Stolz, C., Tsagozis, P., Levchenko, T., Frederick, M. J., Borg, Å., Micke, P., Egevad, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813144106 · Cited by 242
Do, H. T. T., Lee, C. H., & Cho, J. (2020) · Cancers · doi:10.3390/cancers12020287 · Cited by 234
SDF-1 Activity on Microvascular Endothelial Cells
Mirshahi, F., Pourtau, J., Li, H., Muraine, M., Trochon, V., Legrand, E., Vannier, J.-P., Soria, J., Vasse, M., & Soria, C. (2000) · Thrombosis Research · doi:10.1016/s0049-3848(00)00292-9 · Cited by 232
Chaturvedi, P., Gilkes, D. M., Takano, N., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406655111 · Cited by 226
Regulatory mechanisms of hypoxia‐inducible factor 1 activity: Two decades of knowledge
Koyasu, S., Kobayashi, M., Goto, Y., Hiraoka, M., & Harada, H. (2018) · Cancer Science · doi:10.1111/cas.13483 · Cited by 225
Tripathi, C., Tewari, B. N., Kanchan, R. K., Baghel, K. S., Nautiyal, N., Shrivastava, R., Kaur, H., Bhatt, M. L. B., & Bhadauria, S. (2014) · Oncotarget · doi:10.18632/oncotarget.2110 · Cited by 224
Mechanism of Hypoxia-Induced NF-κB
Culver, C., Sundqvist, A., Mudie, S., Melvin, A., Xirodimas, D., & Rocha, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00409-10 · Cited by 223
Li, B.-H., Garstka, M. A., & Li, Z.-F. (2020) · Molecular Immunology · doi:10.1016/j.molimm.2019.11.014 · Cited by 220
Moser, B., Schumacher, C., von Tscharner, V., Clark-Lewis, I., & Baggiolini, M. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99275-6 · Cited by 219
Zagzag, D., Esencay, M., Mendez, O., Yee, H., Smirnova, I., Huang, Y., Chiriboga, L., Lukyanov, E., Liu, M., & Newcomb, E. W. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071197 · Cited by 216
Dunn, L. K., Mohammad, K. S., Fournier, P. G. J., McKenna, C. R., Davis, H. W., Niewolna, M., Peng, X. H., Chirgwin, J. M., & Guise, T. A. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006896 · Cited by 212
Ammirante, M., Shalapour, S., Kang, Y., Jamieson, C. A. M., & Karin, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1416498111 · Cited by 206
Bosco, M. C., Puppo, M., Santangelo, C., Anfosso, L., Pfeffer, U., Fardin, P., Battaglia, F., & Varesio, L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.3.1941 · Cited by 199
Maxwell, P. J., Gallagher, R., Seaton, A., Wilson, C., Scullin, P., Pettigrew, J., Stratford, I. J., Williams, K. J., Johnston, P. G., & Waugh, D. J. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210536 · Cited by 199
Li, Y., Patel, S. P., Roszik, J., & Qin, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01591 · Cited by 195
Stromal Derived Factor-1 (SDF-1/CXCL12) and CXCR4 in renal cell carcinoma metastasis
Pan, J., Mestas, J., Burdick, M. D., Phillips, R. J., Thomas, G. V., Reckamp, K., Belperio, J. A., & Strieter, R. M. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-56 · Cited by 184
Kim, K. S., Rajagopal, V., Gonsalves, C., Johnson, C., & Kalra, V. K. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7211 · Cited by 181
Yan, M., Jene, N., Byrne, D., Millar, E. K., O'Toole, S. A., McNeil, C. M., Bates, G. J., Harris, A. L., Banham, A. H., Sutherland, R. L., et al. (2011) · Breast Cancer Research · doi:10.1186/bcr2869 · Cited by 180
CXCR2‐mediated tumor‐associated neutrophil recruitment is regulated by IFN‐β
Jablonska, J., Wu, C. ‐., Andzinski, L., Leschner, S., & Weiss, S. (2014) · International Journal of Cancer · doi:10.1002/ijc.28551 · Cited by 179
Genetic engineering of human NK cells to express CXCR2 improves migration to renal cell carcinoma
Kremer, V., Ligtenberg, M. A., Zendehdel, R., Seitz, C., Duivenvoorden, A., Wennerberg, E., Colón, E., Scherman-Plogell, A.-H., & Lundqvist, A. (2017) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-017-0275-9 · Cited by 178
The Pervasive Presence of Fluctuating Oxygenation in Tumors
Cárdenas-Navia, L. I., Mace, D., Richardson, R. A., Wilson, D. F., Shan, S., & Dewhirst, M. W. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6387 · Cited by 176
Neural Stem Cell Tropism to Glioma: Critical Role of Tumor Hypoxia
Zhao, D., Najbauer, J., Garcia, E., Metz, M. Z., Gutova, M., Glackin, C. A., Kim, S. U., & Aboody, K. S. (2008) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0146 · Cited by 175
Wang, S.-C., Hong, J.-H., Hsueh, C., & Chiang, C.-S. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2011.128 · Cited by 174
Moon, E. K., Wang, L.-C. S., Bekdache, K., Lynn, R. C., Lo, A., Thorne, S. H., & Albelda, S. M. (2018) · OncoImmunology · doi:10.1080/2162402x.2017.1395997 · Cited by 174
Li, Z., Wang, Y., Shen, Y., Qian, C., Oupicky, D., & Sun, M. (2020) · Science Advances · doi:10.1126/sciadv.aaz9240 · Cited by 171
Dominguez, C., McCampbell, K. K., David, J. M., & Palena, C. (2017) · JCI Insight · doi:10.1172/jci.insight.94296 · Cited by 170
Redjimi, N., Raffin, C., Raimbaud, I., Pignon, P., Matsuzaki, J., Odunsi, K. O., Valmori, D., & Ayyoub, M. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0579 · Cited by 168
Alterations in VHL as potential biomarkers in renal-cell carcinoma
Gossage, L., & Eisen, T. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.42 · Cited by 167
The FIH hydroxylase is a cellular peroxide sensor that modulates HIF transcriptional activity
Masson, N., Singleton, R. S., Sekirnik, R., Trudgian, D. C., Ambrose, L. J. A., Miranda, M. X., Tian, Y., Kessler, B. M., Schofield, C. J., & Ratcliffe, P. J. (2012) · EMBO Reports · doi:10.1038/embor.2012.9 · Cited by 166
Span, P. N., & Bussink, J. (2015) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2014.10.002 · Cited by 163
PD-L1 blockade enhances anti-tumor efficacy of NK cells
Oyer, J. L., Gitto, S. B., Altomare, D. A., & Copik, A. J. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1509819 · Cited by 162
Matsumura, S., & Demaria, S. (2010) · Radiation Research · doi:10.1667/rr1860.1 · Cited by 160
Wuyts, A., Proost, P., Lenaerts, J., Ben‐Baruch, A., Van Damme, J., & Wang, J. M. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2550067.x · Cited by 160
Li, C. X., Ling, C. C., Shao, Y., Xu, A., Li, X. C., Ng, K. T.-P., Liu, X. B., Ma, Y. Y., Qi, X., Liu, H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.032 · Cited by 160
Gijsbers, K., Gouwy, M., Struyf, S., Wuyts, A., Proost, P., Opdenakker, G., Penninckx, F., Ectors, N., Geboes, K., & Van Damme, J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.09.027 · Cited by 158
Cutting Edge: GPR35/CXCR8 Is the Receptor of the Mucosal Chemokine CXCL17
Maravillas‐Montero, J. L., Burkhardt, A. M., Hevezi, P. A., Carnevale, C. D., Smit, M. J., & Zlotnik, A. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401704 · Cited by 158
Noman, M. Z., Janji, B., Hu, S., Wu, J. C., Martelli, F., Bronte, V., & Chouaïb, S. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0405 · Cited by 153
Lanzen, J. L., Braun, R. D., Klitzman, B. M., Brizel, D. M., Secomb, T. W., & Dewhirst, M. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-03-2958 · Cited by 151
Malec, V., Gottschald, O. R., Li, S., Rose, F., Seeger, W., & Hänze, J. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.03.008 · Cited by 149
Colon Cancer Cell Secretes EGF to Promote M2 Polarization of TAM Through EGFR/PI3K/AKT/mTOR Pathway
Lian, G., Chen, S., Ouyang, M., Li, F., Chen, L., & Yang, J. (2019) · Technology in Cancer Research & Treatment · doi:10.1177/1533033819849068 · Cited by 145
Chen, X.-J., Deng, Y.-R., Wang, Z., Wei, W.-F., Zhou, C.-F., Zhang, Y., Yan, R.-M., Liang, L.-J., Zhong, M., Li, L., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1748-1 · Cited by 145
Tabatabai, G., Frank, B., Möhle, R., Weller, M., & Wick, W. (2006) · Brain · doi:10.1093/brain/awl173 · Cited by 144
Foxp3+IL-17+ T cells promote development of cancer-initiating cells in colorectal cancer
Yang, S., Wang, B., Chunying, G., Wu, B., Cai, C., Wang, M., Zhang, B., Liu, T., & Yang, P. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0910506 · Cited by 143
Starnes, T., Rasila, K. K., Robertson, M. J., Brahmi, Z., Dahl, R. E., Christopherson, K. W., & Hromas, R. (2006) · Experimental Hematology · doi:10.1016/j.exphem.2006.05.015 · Cited by 140
Karashima, T., Sweeney, P., Kamat, A. M., Huang, S., Kim, S. J., Bar‐Eli, M., McConkey, D. J., & Dinney, C. P. (2003) · PubMed · Cited by 138
Fiegl, M., Samudio, I. J., Clise-Dwyer, K., Burks, J. K., Mnjoyan, Z. H., & Andreeff, M. (2008) · Blood · doi:10.1182/blood-2008-06-161539 · Cited by 135
Cicchini, L., Westrich, J. A., Xu, T., Vermeer, D. W., Berger, J., Clambey, E. T., Lee, D., Song, J. I., Lambert, P. F., Greer, R. O., et al. (2016) · mBio · doi:10.1128/mbio.00270-16 · Cited by 133
Mossanen, J. C., Kohlhepp, M. S., Wehr, A., Krenkel, O., Liepelt, A., Roeth, A. A., Möckel, D., Heymann, F., Lammers, T., Gaßler, N., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.01.247 · Cited by 133
Jin, F., Brockmeier, U., Otterbach, F., & Metzen, E. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0498 · Cited by 130
Hsieh, C. (2010) · Oncology Reports · doi:10.3892/or_00001027 · Cited by 129
Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells.
Xu, L., Xie, K., Mukaida, N., Matsushima, K., & Fidler, I. J. (1999) · PubMed · Cited by 128
Scheurer, S. B., Raybak, J. N., Roesli, C., Neri, D., & Elia, G. (2004) · PROTEOMICS · doi:10.1002/pmic.200300689 · Cited by 128
Qin, J., Liu, Y., Lu, Y., Liu, M., Li, M., Li, J., & Wu, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-09244-8 · Cited by 127
Lv, M., Xu, Y., Tang, R., Ren, J., Shen, S., Chen, Y., Liu, B., Hou, Y., & Wang, T. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0448 · Cited by 124
Hirani, N., Antonicelli, F. D., Strieter, R. M., Wiesener, M. S., Haslett, C., & Donnelly, S. C. (2001) · Molecular Medicine · doi:10.1007/bf03401959 · Cited by 121
Xu, L., Pathak, P. S., & Fukumura, D. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0953-03 · Cited by 118
Ke, X., Chen, C., Song, Y., Cai, Q., Li, J., Tang, Y., Han, X., Qu, W., Chen, A., Wang, H., et al. (2019) · Oncology Letters · doi:10.3892/ol.2019.10956 · Cited by 118
Yang, J., & Richmond, A. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.01.010 · Cited by 116
CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3
Müeller, A., Meiser, A., McDonagh, E. M., Fox, J. M., Petit, S. J., Xanthou, G., Williams, T. J., & Pease, J. E. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1006645 · Cited by 116
Specific Recruitment of γδ Regulatory T Cells in Human Breast Cancer
Ye, J., Ma, C., Wang, F., Hsueh, E. C., Tóth, K., Huang, Y., Mo, W., Liu, S., Han, B., Varvares, M. A., et al. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-0348 · Cited by 114
Regulation of interleukin-8 expression by reduced oxygen pressure in human glioblastoma
Desbaillets, I., Diserens, A., de Tribolet, N., Hamou, M., & Meir, E. G. V. (1999) · Oncogene · doi:10.1038/sj.onc.1202424 · Cited by 112
Bullen, J. W., Tchernyshyov, I., Holewinski, R. J., Devine, L. R., Wu, F., Venkatraman, V., KASS, D., Cole, R. N., Eyk, J. E. V., & Semenza, G. L. (2016) · Science Signaling · doi:10.1126/scisignal.aaf0583 · Cited by 112
Storti, P., Bolzoni, M., Donofrío, G., Airoldi, I., Guasco, D., Toscani, D., Martella, E., Lazzaretti, M., Mancini, C., Agnelli, L., et al. (2013) · Leukemia · doi:10.1038/leu.2013.24 · Cited by 111
Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer
Seo, E. J., Kim, D. K., Jang, I. H., Choi, E. J., Shin, S., Lee, S. I., Kwon, S., Kim, K., Suh, D., & Kim, J. H. (2016) · Oncotarget · doi:10.18632/oncotarget.10954 · Cited by 109
Shi, Q., Le, X., Abbruzzese, J. L., Wang, B., Mujaida, N., Matsushima, K., Huang, S., Xiong, Q., & Xie, K. (1999) · Journal of Interferon & Cytokine Research · doi:10.1089/107999099312821 · Cited by 108
Anoxia-Induced Up-Regulation of Interleukin-8 in Human Malignant Melanoma
Kunz, M., Hartmann, A., Flory, E., Toksoy, A., Koczan, D., Thiesen, H., Mukaida, N., Neumann, M., Rapp, U. R., Bröcker, E., et al. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65174-7 · Cited by 107
Xie, F., Liu, L.-B., Shang, W.-Q., Chang, K., Meng, Y., Mei, J., Yu, J., Li, D., & Li, M. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.04.029 · Cited by 106
The HIF-1α/CXCR4 pathway supports hypoxia-induced metastasis of human osteosarcoma cells
Guan, G., Zhang, Y., Lu, Y. W., Liu, L., Shi, D., Wen, Y., Yang, L., Ma, Q., Liu, T., Zhu, X., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.034 · Cited by 106
The Distinct Roles of CXCR3 Variants and Their Ligands in the Tumor Microenvironment
Reynders, N., Abboud, D., Baragli, A., Noman, M. Z., Rogister, B., Niclou, S. P., Heveker, N., Janji, B., Hanson, J., Szpakowska, M., et al. (2019) · Cells · doi:10.3390/cells8060613 · Cited by 106
Wang, J., Yu, F., Jia, X., Iwanowycz, S., Wang, Y., Huang, S., Ai, W., & Fan, D. (2014) · International Journal of Cancer · doi:10.1002/ijc.29151 · Cited by 105
HIF-1 Induction Attenuates Nrf2-Dependent IL-8 Expression in Human Endothelial Cells
Łoboda, A., Stachurska, A., Florczyk, U., Rudnicka, D., Jaźwa, A., Węgrzyn, J., Kozakowska, M., Stalińska, K., Poellinger, L., Levonen, A., et al. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2211 · Cited by 105
CXCL14 is a natural inhibitor of the CXCL12–CXCR4 signaling axis
Tanegashima, K., SUZUKI, K. S., Nakayama, Y., Tsuji, K., Shigenaga, A., Otaka, A., & Hara, T. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.04.046 · Cited by 105
Martin, S. K., Diamond, P., Williams, S. A., To, L. B., Peet, D. J., Fujii, N., Gronthos, S., Harris, A. L., & Zannettino, A. C. W. (2009) · Haematologica · doi:10.3324/haematol.2009.015628 · Cited by 105
Determination and comparison of specific activity of the HIF‐prolyl hydroxylases
Tuckerman, J. R., Zhao, Y., Hewitson, K. S., Tian, Y., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.09.005 · Cited by 104
Hypoxia increases the metastatic ability of breast cancer cells via upregulation of CXCR4
Cronin, P. A., Wang, J. H., & Redmond, H. P. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-225 · Cited by 103
Li, M., Lü, Y., Xu, Y., Wang, J., Zhang, C., Du, Y., Wang, L., Li, L., Wang, B., Shen, J., et al. (2018) · Gene · doi:10.1016/j.gene.2018.07.018 · Cited by 102
Devignes, C.-S., Aslan, Y., Brenot, A., Devillers, A., Schepers, K., Fabre, S., Chou, J., Casbon, A.-J., Werb, Z., & Provot, S. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1718009115 · Cited by 100
Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling
Matsuoka, J., Yashiro, M., Doi, Y., Fuyuhiro, Y., Kato, Y., Shinto, O., Noda, S., Kashiwagi, S., Aomatsu, N., Hirakawa, T., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062310 · Cited by 99
Hypoxia Promotes Migration and Induces CXCR4 Expression via HIF-1α Activation in Human Osteosarcoma
Guo, M., Cai, C., Zhao, G., Qiu, X., Zhao, H., Ma, Q., Tian, L., Li, X., Hu, Y., Liao, B., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090518 · Cited by 99
Opposite effects of HIF-1α and HIF-2α on the regulation of IL-8 expression in endothelial cells
Florczyk, U., Czauderna, S., Stachurska, A., Tertil, M., Nowak, W. N., Kozakowska, M., Poellinger, L., Józkowicz, A., Łoboda, A., & Dulak, J. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.08.023 · Cited by 99
Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma
Nakashiro, K. (2009) · Oncology Reports · doi:10.3892/or_00000275 · Cited by 99
Tumor-Derived CXCL1 Promotes Lung Cancer Growth via Recruitment of Tumor-Associated Neutrophils
Yuan, M., Zhu, H., Xu, J., Zheng, Y., Cao, X., & Liu, Q. (2016) · Journal of Immunology Research · doi:10.1155/2016/6530410 · Cited by 98
HUMAN B CELL-ATTRACTING CHEMOKINE 1 (BCA-1; CXCL13) IS AN AGONIST FOR THE HUMAN CXCR3 RECEPTOR
Jenh, C., Cox, M. A., Hipkin, W., Lu, T., Pugliese‐Sivo, C., Gonsiorek, W., Chou, C., Narula, S. K., & Zavodny, P. J. (2001) · Cytokine · doi:10.1006/cyto.2001.0923 · Cited by 97
Sun, X., Lei, W., Chen, Q., & Terek, R. M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-17 · Cited by 97
Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression.
Asosingh, K., Raeve, H. D., Ridder, M. D., Storme, G. A., Willems, A., Riet, I. V., Camp, B. V., & Vanderkerken, K. (2005) · PubMed · Cited by 97
HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk
Wang, Y., Weng, X., Wang, L., Hao, M., Li, Y., Hou, L., Liang, Y., Wu, T., Yao, M., Lin, G., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci99974 · Cited by 95
Hypoxia differentially regulated CXCR4 and CXCR7 signaling in colon cancer
Romain, B., Hachet‐Haas, M., Rohr, S., Brigand, C., Galzi, J., Gaub, M., Pencreach, E., & Guénot, D. (2014) · Molecular Cancer · doi:10.1186/1476-4598-13-58 · Cited by 94
Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells.
Schutyser, E., Su, Y., Yu, Y., Gouwy, M., Zaja‐Milatovic, S., Damme, J. V., & Richmond, A. J. (2007) · PubMed · doi:10.1684/ecn.2007.0087 · Cited by 94
Zhu, P., Du, X. L., Lu, G., & Zhu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.17054 · Cited by 94
Wu, X. G., Zhu, Y., Huang, W., Li, J., Zhang, B., Li, Z., & Yang, X. (2018) · Advanced Science · doi:10.1002/advs.201700859 · Cited by 94
Wang, R., Feng, W., Wang, H., Wang, L., Yang, X. Q., Yang, F., Zhang, Y., Liu, X., Zhang, D., Ren, Q., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.032 · Cited by 94
Galindo-Izquierdo, M., Santiago, B., Alcamí, J., Rivero, M., Martin‐Serrano, J., & Pablos, J. L. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01412.x · Cited by 88
Haqqani, A. S., Sandhu, J. K., & Birnboim, H. C. (2000) · Neoplasia · doi:10.1038/sj.neo.7900110 · Cited by 88
Fujita, N., Markova, D., Anderson, D. G., Chiba, K., Toyama, Y., Shapiro, I. M., & Risbud, M. V. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.334466 · Cited by 87
CXCR4 targeted dendrimer for anti-cancer drug delivery and breast cancer cell migration inhibition
Chittasupho, C., Anuchapreeda, S., & Sarisuta, N. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.07.003 · Cited by 87
Neuhaus, T., Stier, S., Totzke, G., Grünewald, E., Fronhoffs, S., Sachinidis, A., Vetter, H., & Ko, Y. D. (2003) · Cell Proliferation · doi:10.1046/j.1365-2184.2003.00262.x · Cited by 86
Bhuria, V., Xing, J., Scholta, T., Bùi, K. C., Nguyen, M. L. T., Malek, N. P., Bozko, P. M., & Plentz, R. R. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111671 · Cited by 85
Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer
Santagata, S., Napolitano, M., D’Alterio, C., Desicato, S., Maro, S. D., Marinelli, L., Fragale, A., Buoncervello, M., Persico, F., Gabriele, L., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.20363 · Cited by 84
Rofstad, E. K., Mathiesen, B. S., Henriksen, K., Kindem, K., & Galappathi, K. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3039 · Cited by 83
Selective depletion of metastatic stem cells as therapy for human colorectal cancer
Céspedes, M. V., Unzueta, U., Aviñó, A. M., Gallardo, A., Álamo, P., Sala, R., Sánchez‐Chardi, A., Casanova, I., Mangues, M. A., Pousa, A. L., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708772 · Cited by 83
Shi, H., Han, X., Sun, Y., Shang, C., Wei, M., Ba, X., & Zeng, X. (2018) · Cancer Science · doi:10.1111/cas.13809 · Cited by 83
Ravenna, L., Principessa, L., Verdina, A., Salvatori, L., Russo, M. A., & Petrangeli, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096250 · Cited by 80
miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis
Sun, X., Charbonneau, C., Lei, W., Chen, Q., & Terek, R. M. (2015) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-14-0697 · Cited by 80
Park, S., Lee, S. J., Nam, S., & Im, D. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14082 · Cited by 80
Triner, D. A., Xue, X., Schwartz, A. J., Jung, I., Colacino, J. A., & Shah, Y. M. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00481-16 · Cited by 79
Rofstad, E. K., & Halsør, E. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600052 · Cited by 78
Liu, Y.-L., Yu, J., Song, X., Wang, X.-W., Xing, L., & Gao, B. (2006) · Cancer Biology & Therapy · doi:10.4161/cbt.5.10.3162 · Cited by 78
Hypoxia promotes the invasion and metastasis of laryngeal cancer cells via EMT
Zuo, J., Wen, J., Lei, M., Wen, M., Li, S., Lv, X., Luo, Z., & Wen, G. (2016) · Medical Oncology · doi:10.1007/s12032-015-0716-6 · Cited by 78
Toffoli, S., Féron, O., Raes, M. J., & Michiels, C. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2007.06.002 · Cited by 77
Tulotta, C., Stefanescu, C., Chen, Q., Torraca, V., Meijer, A. H., & Snaar-Jagalska, E. B. (2019) · Scientific Reports · doi:10.1038/s41598-019-38643-2 · Cited by 77
Warner, K. A., Miyazawa, M., Cordeiro, M. M. R., et al. (2008) · Neoplasia · doi:10.1593/neo.07815 · Cited by 75
Blengio, F., Raggi, F., Pierobon, D., Cappello, P., Eva, A., Giovarelli, M., Varesio, L., & Bosco, M. C. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.02.002 · Cited by 75
Hu, Z., Chen, J., Zhou, S., Yang, N., Duan, S., Zhang, Z., Su, J., He, J., Zhang, Z., Lü, X., et al. (2017) · Theranostics · doi:10.7150/thno.16236 · Cited by 75
Zheng, X., He, X., Zhang, L., Qin, H., Lin, X., Liu, X., Zhou, C., Liu, H., Hu, T., Cheng, H., et al. (2018) · Gastroenterology report · doi:10.1093/gastro/goy017 · Cited by 75
Role of CXCR3 signaling in response to anti-PD-1 therapy
Han, X., Wang, Y., Sun, J., Tan, T., Cai, X., Lin, P., Tan, Y., Zheng, B., Wang, B., Wang, J., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.08.067 · Cited by 75
Chemokines mediate mesenchymal stem cell migration toward gliomas in vitro
Xu (2010) · Oncology Reports · doi:10.3892/or_00000796 · Cited by 73
Wang, J., Hu, W., Wang, K., Yu, J., Luo, B., Luo, G., Wang, W., Wang, H., Li, J., & Wen, J. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3371 · Cited by 73
Oka, T., Sugaya, M., Takahashi, N., Takahashi, T., Shibata, S., Miyagaki, T., Asano, Y., & Sato, S. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601607 · Cited by 73
Cycling hypoxia promotes a pro-inflammatory phenotype in macrophages via JNK/p65 signaling pathway
Delprat, V., Tellier, C., Demazy, C., Raes, M. J., Féron, O., & Michiels, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-57677-5 · Cited by 73
Tafani, M., Russo, A., Vito, M. D., Sale, P., Pellegrini, L., Schito, L., Gentileschi, S., Bracaglia, R., Marandino, F., Garaci, E., et al. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01493.x · Cited by 72
Chen, W.-L., Wang, C.-C., Lin, Y., Wu, C., & Hsieh, C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0758-8 · Cited by 72
Polotsky, V. Y., Savransky, V., Bevans‐Fonti, S., Reinke, C., Li, J., Grigoryev, D. N., & Shimoda, L. A. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00091.2009 · Cited by 71
Regulation of Interleukin-8 Expression by Cellular pH in Human Pancreatic Adenocarcinoma Cells
Shi, Q., Le, X., Wang, B., Xiong, Q., Abbruzzese, J. L., & Xie, K. (2000) · Journal of Interferon & Cytokine Research · doi:10.1089/10799900050198471 · Cited by 70
Menu, E., Asosingh, K., Indraccolo, S., Raeve, H. D., Riet, I. V., Valckenborgh, E. V., Broek, I. V., de Broek, I. V., Fujii, N., Tamamura, H., et al. (2006) · PubMed · Cited by 70
Bao, Y., Wang, Z., Liu, B., Lu, X. L., Xiong, Y., Shi, J., Li, P., Chen, J., Zhang, Z., Chen, M., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0452-4 · Cited by 69
Dong, L., You, S., Zhang, Q., Osuka, S., Devi, N. S., Kaluz, Š., Ferguson, J. H., Yang, H., Chen, G., Wang, B., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1368 · Cited by 66
A Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in Stroke
Lee, H., Liu, S., Lin, C.-H., Lee, S. W., Hsu, C. Y., Sytwu, H., Hsieh, C., & Shyu, W. (2017) · Theranostics · doi:10.7150/thno.17558 · Cited by 65
Temporal regulation of HIF-1 and NF-κB in hypoxic hepatocarcinoma cells
Jiang, Y., Zhu, Y. J., Wang, X., Gong, J., Hu, C., Guo, B., Zhu, B., & Li, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3352 · Cited by 64
Cited by
Macrophages at the interface of the co-evolving cancer ecosystem
Kloosterman, D. J., & Akkari, L. (2023) · Cell · doi:10.1016/j.cell.2023.02.020 · Cited by 427
Korbecki, J., Simińska, D., Gąssowska-Dobrowolska, M., Listos, J., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910701 · Cited by 380
Self-citationThe role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF
Ghalehbandi, S., Yuzugulen, J., Pranjol, M. Z. I., & Pourgholami, M. H. (2023) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2023.175586 · Cited by 362
Metadata
- Authors
- Korbecki, J., Kojder, K., Kapczuk, P., Kupnicka, P., Gawrońska-Szklarz, B., Gutowska, I., Chlubek, D., & Baranowska-Bosiacka, I.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-01-15
- Volume
- 22
- Issue
- 2
- Pages
- 843
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3118518279
- Cited by
- 273
- References
- 314
- FWCI
- 13.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.